Last reviewed · How we verify
NCT04444583: REFLECS-FI
Recognition of Heart Failure With Micro Electro-Mechanical Sensors (REFLECS) FI
trial in Heart Failure in 155 participants. Completed in 31 December 2024.
31 December 2021
Quick facts
| Lead sponsor | Precordior Ltd |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 155 |
| Start date | 1 June 2020 |
| Primary completion | 31 December 2021 |
| Estimated completion | 31 December 2024 |
| Sites | 2 locations across Finland |
Conditions studied
- Heart Failure — all drugs for Heart Failure →
- Heart Diseases — all drugs for Heart Diseases →
- Cardiovascular Diseases — all drugs for Cardiovascular Diseases →
Sponsor
Precordior Ltd
Who can join
18 and older, any sex, with Heart Failure or Heart Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this study the ability of smartphone sensors (accelerometer and gyroscope) to identify patients with heart failure will be studied.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Smartphone-Based Recognition of Heart Failure by Means of Microelectromechanical Sensors.
Haddad F, Saraste A, Santalahti KM, Pänkäälä M, et al · · 2024 · cited 9× · PMID 38573263 · DOI 10.1016/j.jchf.2024.01.022
Verify or expand the search:
- PubMed search for NCT04444583
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Heart Failure
Currently open trials in the same condition.
- NCT06118983 — Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF) · NA · recruiting
- NCT07496372 — Efficacy and Safety of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Injection (HiCM-188) in Advanced Heart · Phase 3 · recruiting
- NCT07527156 — Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure · Phase 4 · recruiting
- NCT07263035 — Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure · Phase 4 · recruiting
- NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting
Other Precordior Ltd trials
Trials by the same sponsor.
- NCT06944405 — Implementation for Heart Failure Therapies Post-discharge Followed by CardiOSIgnal at HOME · NA · not yet recruiting
- NCT05936827 — Gyrocardiography- A New Non-invasive Cardiac Measurement Method to Measure Exercise Capacity and Cardiorespiratory Fitne · completed
- NCT04290091 — Detection of Coronary Artery Disease With Micro Electro-Mechanical Sensors · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04444583 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Precordior Ltd
- Last refreshed: 14 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04444583.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing